The same chemical that makes yoga mats pliable, azodicarbonamide, is now under formal safety reassessment by the FDA for its presence in your bread and pastries. The FDA also launched a reassessment of butylated hydroxytoluene (BHT). These additives have been staples in food products for decades, but the FDA is now formally re-evaluating their safety. This marks a significant shift from the agency's past acceptance of long-standing food additive statuses. Based on the FDA's proactive requests, food manufacturers will likely face pressure to reformulate products, potentially leading to the phase-out of these controversial ingredients.
What Are BHT and ADA?
BHT, an antioxidant, prevents spoilage in foods. ADA, a dough conditioner, enhances texture in baked goods. Both have been widely used, but their long-standing presence doesn't guarantee future approval. The Food Dive notes this reassessment challenges the 'Generally Recognized As Safe' (GRAS) status of many such chemicals.
FDA's Formal Information Request
On May 13, 2026, the law firm Keller and Heckman reported the FDA issued formal Requests for Information (RFIs) for BHT and ADA. This move shows the agency is actively gathering new scientific data and public input. It puts the onus on manufacturers to provide robust safety evidence, a significant shift in regulatory approach.
Why Now? A Shifting Regulatory Landscape
The FDA's action aligns with a broader trend to re-evaluate long-approved food additives. Evolving scientific understanding and consumer concerns drive this. By targeting BHT and ADA, the FDA makes it clear: a long history no longer guarantees an additive's safety. This effectively ends the implicit 'grandfather clause' for many food ingredients and signals a proactive re-evaluation of the entire approved additive list.
What Happens After the Deadline?
Responses to the RFIs for BHT and ADA are due by July 13, 2026, a tight 60-day window, as reported by Lawbc. The aggressive timeline indicates the FDA's accelerated pace. It will likely catch many food manufacturers unprepared, forcing them to quickly compile and submit comprehensive safety data. This rapid response period will heavily influence the FDA's final decisions and could lead to significant industry changes.
Given the FDA's accelerated timeline and proactive stance, it appears likely that food manufacturers will soon face mandatory reformulations, fundamentally altering the ingredient lists of many everyday products.
